Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abstract Importance Access to testing is key to a successful response to the COVID-19 pandemic. Objective To determine the geographic accessibility to SARS-CoV-2 testing sites in the United States, as quantified by travel time. Design Cross-sectional analysis of SARS-CoV-2 testing sites as of April 7, 2020 in relation to travel time. Setting United States COVID-19 pandemic. Participants The United States, including the 48 contiguous states and the District of Columbia. Exposures Population density, percent minority, percent uninsured, and median income by county from the 2018 American Community Survey demographic data. Main Outcome SARS-CoV-2 testing sites identified in two national databases (Carbon Health and CodersAgainstCovid), geocoded by address. Median county 1 km 2 gridded friction surface of travel times, as a measure of geographic accessibility to SARS-CoV-2 testing sites. Results 6,236 unique SARS-CoV-2 testing sites in 3,108 United States counties were identified. Thirty percent of the U.S. population live in a county (N = 1,920) with a median travel time over 20 minutes. This was geographically heterogeneous; 86% of the Mountain division population versus 5% of the Middle Atlantic population lived in counties with median travel times over 20 min. Generalized Linear Models showed population density, percent minority, percent uninsured and median income were predictors of median travel time to testing sites. For example, higher percent uninsured was associated with longer travel time ( β = 0.41 min/percent, 95% confidence interval 0.3-0.53, p = 1.2×10 −12 ), adjusting for population density. Conclusions and Relevance Geographic accessibility to SARS-Cov-2 testing sites is reduced in counties with lower population density and higher percent of minority and uninsured, which are also risk factors for worse healthcare access and outcomes. Geographic barriers to SARS-Cov-2 testing may exacerbate health inequalities and bias county-specific transmission estimates. Geographic accessibility should be considered when planning the location of future testing sites and interpreting epidemiological data. Key Points SARS-CoV-2 testing sites are distributed unevenly in the US geography and population. Median county-level travel time to SARS-CoV-2 testing sites is longer in less densely populated areas, and in areas with a higher percentage of minority or uninsured populations. Improved geographic accessibility to testing sites is imperative to manage the COVID-19 pandemic in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Cited by
Sannigrahi, S., Pilla, F., Basu, B., Basu, A. S., & Molter, A. (2020) · Sustainable Cities and Society · doi:10.1016/j.scs.2020.102418 · Cited by 317
Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study
Rader, B., White, L. F., Burns, M. R., Chen, J., Brilliant, J., Cohen, J., Shaman, J., Brilliant, L., Kraemer, M. U. G., Hawkins, J. B., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30293-4 · Cited by 307
Self-citationUse of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022
Rader, B., Gertz, A., Iuliano, A. D., Gilmer, M., Wronski, L., Astley, C. M., Sewalk, K., Varrelman, T. J., Cohen, J., Parikh, R., et al. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7113e1 · Cited by 223
Self-citationBilal, U., Tabb, L. P., Barber, S., & Diez Roux, A. V. (2021) · Annals of Internal Medicine · doi:10.7326/m20-3936 · Cited by 183
“Barriers to testing can include unequal location of testing sites (36), lack of vehicle ownership (37), lack of health insurance (38), lack of a usual source of care for referrals (39), and potential mistrust of the medical system (40).”
BackgroundMartins-Filho, P. R., de Souza Araújo, A. A., Quintans-Júnior, L. J., & Santos, V. S. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa128 · Cited by 72
Metadata
- Authors
- Rader, B., Astley, C. M., Sy, K. T. L., Sewalk, K., Hswen, Y., Brownstein, J. S., & Kraemer, M. U. G.
- Venue
- Journal of Travel Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-15
- Volume
- 27
- Issue
- 7
- ISSN
- 1195-1982 (ISSN-L)
- 1708-8305
- OpenAlex
- W3025818509
- Cited by
- 150
- References
- 2
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates. https://app.cochat.ai/papers/10.1093/jtm/taaa076
- The paper
- Rader, B., Astley, C. M., Sy, K. T. L., Sewalk, K., Hswen, Y., Brownstein, J. S., & Kraemer, M. U. G. (2020). Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taaa076
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.